Best Life Sciences Companies in Hamilton, Canada
The 35 best Life Sciences companies in Hamilton, Canada in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Fusion Pharmaceuticals.
Our analysis of 50 Life Sciences companies
$27.5b in tracked funding; 76% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences companies in Hamilton
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Fusion Pharmaceuticals Developer of targeted alpha therapeutics for the treatment of cancers | $171M | 80 mo ago | Acquired | — | 2014 | WordPressApple iCloud MailMySQL+21 | 294 patents PSMA-targeted radiopharmaceuticals for cancer therapy combined with DNA damage response inhibitors | — |
| 2 | Actlabs Provider of analytical testing and development services for various industries. | $2M | 257 mo ago | Series A | Eric Hoffman Founder | 1987 | WordPressPleskMySQL+28 | — | — |
| 3 | CTT Pharmaceuticals Oral thin-film wafers for drug delivery | $1M | 100 mo ago | Public | — | 1996 | — | — | — |
| 4 | Affinity Biologicals Range of products for thrombosis, hemostasis, and medical diagnostics | $500K | 183 mo ago | Acquired | — | 1987 | WordPressMySQLPHP+13 | — | — |
| 5 | StokedBio Developer of therapeutics based on AI technology 45Talent top 28%AI top 45%Funding top 46%Market bottom 37% All 5 signals ▾Talenttop 28% AItop 45% Fundingtop 46% Marketbottom 37% Globalbottom 29% Talent: 3 named leaders on record · 3 C-suite/founder profiles curated AI: Product described with: ai-based rank vs industry peers · Fliar Intelligence Index 45/100 | $366K | 4 mo ago | Seed | Chris Sinclair Co-Founder | 2024 | — | — | — |
| 6 | HiNT Developer of a wearable device for stroke detection | $70K | 111 mo ago | Deadpooled | Ahmed Elmeligi Co-Founder & CEO | 2016 | — | — | — |
| 7 | ToeFX Company discovering and developing treatment of toenail fungus (onychomycosis) | $30K | 87 mo ago | Seed | Monika Yazdanian Co-Founder & CEO | 2016 | WordPressMySQLPHP+28 | 17 patents Photodynamic antimicrobial therapy devices and photosensitizer formulations for fungal nail infections | — |
| 8 | AgeRate Platform offering at home biological age test toolkit | $25K | 19 mo ago | Seed | Nathan Cawte Co-Founder | 2018 | — | — | — |
Top 10 Life Sciences companies in Hamilton
#1
Seed · Hamilton, Ontario · founded 2024$365.5Kraised▾
Developer of therapeutics based on AI technology. It offers AI-based platform for molecular property prediction and molecular design for drug discovery for antibacterial, antifungal, antiviral, and cancer applications.
- May 2026Seed$365.5K
#2
Acquired · Hamilton, Ontario · founded 2014 · 106 employees$170.9Mraised▾
Developer of targeted alpha therapeutics for the treatment of cancers. The company's product line include FPI-1434 combines the targeting of a human experienced antibody with Fusion’s linker technology and the alpha-emitting cytotoxic isotope Actinium-225 to induce cancer cell death. It is being developed for patients with solid tumors that internalize the insulin-like growth factor-1 receptor (IGF–1R), a rapidly internalizing membrane protein.
- Jan 2020Series B$19.9M
- Apr 2019Series B$105M
- Sep 2017Series A$21M
- Feb 2017Series A$25M
#3
Seed · Hamilton, Ontario · founded 2018$25Kraised▾
Platform offering at home biological age test toolkit. It provides a personalized insights and recommendations for living a longer, healthier life by combining epigenetic testing. It allows users to receive the results through the mobile app, which provides personalized insights and recommendations based on the biomarker data. It allows individuals to take a proactive approach to managing the health and aging process.
- Jan 2025Seed$25K
- 2020Seed—
#4
Series A · Hamilton, Ontario · founded 1987 · 452 employees$2Mraised▾
{}
- Apr 2005Series A$2M
#5
Public · Hamilton, Ontario · founded 1996$1Mraised▾
CTT Pharma is developing fast dissolving oral thin film wafers of opioids and medical marijuana for treatment of chronic pain, post-operative surgical pain, arthritis and joint pain. This intraoral drug delivery system is a thin, flexible, and quick-dissolving film that is placed on the top or the floor of the tongue where it is retained and rapidly releases the active agent for local and/or systemic absorption.
- May 2018Post IPO$1M
#6
Acquired · Hamilton, Ontario · founded 1987 · 25 employees$500Kraised▾
Affinity Biologicals provides a range of products for thrombosis and hemostasis research and medical diagnostics. Its products include Coagulation antibodies, Analyte specific reagents, ELISA Kits. It also provides deficient plasmas, factor inhibitor plasmas, frozen control plasmas, lyophilized control plasmas, and also custom plasmas.
- Jun 2011Unattributed$500K
#7
Deadpooled · Hamilton, Ontario · founded 2016$70Kraised▾
HiNT has developed a wearable headband for monitoring device for detecting heart stroke. The device monitors the user's risk of getting heart stroke and send alerts to patients, caregivers, and emergency services in the case of a stroke. Some of the partners are The Forge, WBooth, Innovation Factory, Ontario Brain Institute, and McMaster University.
- Jun 2017Grant (prize money)$50K
- Apr 2016Grant (prize money)$20K
#8
Seed · Hamilton, Ontario · founded 2016 · 7 employees$30Kraised▾
ToeFx is a biopharma company engaged in discovering and developing treatment of toenail fungus (onychomycosis). Its technology is based on photodynamic therapy (PDT), which includes light radiation and photosensitizer. They have collaboration with McMaster University.
- Jun 2019Seed$30K
#9
Seed · Hamilton, Ontario · founded 2013—raised▾
Exerkine is a developer of a drug delivery platform and identifies therapeutic compounds. The company has developed Exerkines which are compounds released into the blood used to treat to rare genetic and aging-associated diseases.
- Apr 2022Seed—
#10
Seed · Hamilton, Ontario · founded 2016 · 10 employees—raised▾
Epineuron Technologies provides medical devices for peripheral nerve injury treatment. It is involved in the treatment of transection, crush, compression, traction, and ischemia causing physical disability. The technology is used for the electrical stimulation of nerves for bosting the natural biochemical process for healing and repair.
- May 2020Seed—
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in Canada
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 990 Canada-affiliated papers.
- Ministry of Agriculture118
- Ministry of Education70
- University of Toronto61
- McGill University60
- Agriculture and Agri-Food Canada58
- Gene3→32
- Mutant2→13
- Genome2→12
- Transcription factor2→11
- Transcription (linguistics)1→9
- Gene2→40
- Fermentation1→12
- Antimicrobial1→9
- Population1→9
- Agriculture1→8
- Agriculture3→10
- Antibiotic resistance3→10
- Antimicrobial1→6
- Human health2→7
- Microbiome2→6
Where biotechnology is researched across Canada
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Who's filing biotechnology patents in Canada
Canada biotechnology patent filing is accelerating — 18,553 filings from 8,000 assignees (2016–2025), led by UNIV British Columbia, UNIV Health Network, NAT RES Council Canada; annual filings 1716→1734.
- UNIV British Columbia1568
- UNIV Health Network1207
- NAT RES Council Canada900
- UNIV Alberta749
- CA NAT Research Council697
- Medicago680
- UNIV Saskatchewan597
- Zymeworks594
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.